Abstract:BackgroundIn the United States, about 3 million people have autism spectrum disorder (ASD), and around 1 out of 59 children are diagnosed with ASD. People with ASD have characteristic social communication deficits and repetitive behaviors. The causes of this disorder remain unknown; however, in up to 25% of cases, a genetic cause can be identified. Detecting ASD as early as possible is desirable because early detection of ASD enables timely interventions in children with ASD. Identification of ASD based on objective pathogenic mutation screening is the major first step toward early intervention and effective treatment of affected children. ObjectiveRecent investigation interrogated genomics data for detecting and treating autism disorders, in addition to the conventional clinical interview as a diagnostic test. Since deep neural networks perform better than shallow machine learning models on complex and high-dimensional data, in this study, we sought to apply deep learning to genetic data obtained across thousands of simplex families at risk for ASD to identify contributory mutations and to create an advanced diagnostic classifier for autism screening. MethodsAfter preprocessing the genomics data from the Simons Simplex Collection, we extracted top ranking common variants that may be protective or pathogenic for autism based on a chi-square test. A convolutional neural network–based diagnostic classifier was then designed using the identified significant common variants to predict autism. The performance was then compared with shallow machine learning–based classifiers and randomly selected common variants. ResultsThe selected contributory common variants were significantly enriched in chromosome X while chromosome Y was also discriminatory in determining the identification of autistic individuals from nonautistic individuals. The ARSD, MAGEB16, and MXRA5 genes had the largest effect in the contributory variants. Thus, screening algorithms were adapted to include these common variants. The deep learning model yielded an area under the receiver operating characteristic curve of 0.955 and an accuracy of 88% for identifying autistic individuals from nonautistic individuals. Our classifier demonstrated a considerable improvement of ~13% in terms of classification accuracy compared to standard autism screening tools. ConclusionsCommon variants are informative for autism identification. Our findings also suggest that the deep learning process is a reliable method for distinguishing the diseased group from the control group based on the common variants of autism.

Pathogenic/likely pathogenic mutations identified in Vietnamese children diagnosed with autism spectrum disorder using high-resolution SNP genotyping platform

Autism Spectrum Disorder Early in Development Associated with CHD8 Mutations among Two Chinese Children

Diagnostic Classification and Prognostic Prediction Using Common Genetic Variants in Autism Spectrum Disorder: Genotype-Based Deep Learning

De novo copy number variations in candidate genomic regions in patients of severe autism spectrum disorder in Vietnam

Detection of Clinically Relevant Genetic Variants in Autism Spectrum Disorder by Whole-Genome Sequencing

Targeted Sequencing and Clinical Strategies in Children with Autism Spectrum Disorder: A Cohort Study

De novo genic mutations among a Chinese autism spectrum disorder cohort

Early screening and diagnosis of autism spectrum disorders in Vietnam: A population-based cross-sectional survey

Genome Sequencing Identifies 13 Novel Candidate Risk Genes for Autism Spectrum Disorder in a Qatari Cohort

Inherited and multiple de novo mutations in autism/developmental delay risk genes suggest a multifactorial model

Targeted Sequencing Identifies Risk Variants in 202 Candidate Genes for Neurodevelopmental Disorders

Targeted sequencing and functional analysis reveal brain-size-related genes and their networks in autism spectrum disorders

Identification of De Novo Mutations in the Chinese Autism Spectrum Disorder Cohort Via Whole-Exome Sequencing Unveils Brain Regions Implicated in Autism

Genome-wide characteristics of de novo mutations in autism

Multiplex Targeted Sequencing Identifies Recurrently Mutated Genes in Autism Spectrum Disorders

Impact of gene polymorphisms involved in the vitamin D metabolic pathway on the susceptibility to and severity of autism spectrum disorder

Association of genetic variants with autism spectrum disorder in Japanese children revealed by targeted sequencing

Whole Genome Sequencing and Variant Discovery in the ASPIRE Autism Spectrum Disorder Cohort

The contribution of de novo coding mutations to autism spectrum disorder

Copy Number Variation and Neural Pathway Analysis of Children with Autism Spectrum Disorder from a Large Han Chinese Population-Based Cross-Sectional Study

Prevalence and phenotypic impact of rare potentially damaging variants in autism spectrum disorder